APOE p.Arg176Pro
c.527G>C · VCV4293341
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8375 | likely pathogenic · top 3% in APOE |
|---|---|---|
| REVEL | 0.604 | indeterminate |
| SaProt | LLR -10.16 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.9 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 2,622 bp · p 0.6 · regional, not allelic |
| Overall | ||
| CADD | 25.4 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- APOE
- Protein
- p.Arg176Pro
- Coding
- c.527G>C
- MANE Select
- NM_000041
- Type
- single nucleotide variant
- Location
- chr19:44908823 (GRCh38)
- Gene constraint
- LOEUF 1.319 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 76.13 · 31 PDB
- Residue 176
- the '8 x 22 aa approximate tandem repeats' region; a UniProt-annotated variant site (in hlpp3; apoe2, apoe2 fukuoka, apoe1 weisgraber and apoe3**; apoe3** is associated with hlpp3; changed protein structure; decreased binding to ldlr and other lipoprotein receptors; decreased in vitro binding to heparin; no effect on distribution among plasma lipoproteins); an α-helix
Disease context
lipoprotein glomerulopathy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Lipoprotein glomerulopathy (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult, Childhood, Elderly
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- APOE p.Arg43Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
- APOE p.Arg269Gly Uncertain significance ★★ ⚠ same condition
- APOE p.Glu230Lys Uncertain significance ★★ ⚠ same condition
- APOE p.Gly145Asp Uncertain significance ★★ same condition
- APOE p.Ala217= Benign/Likely benign ★★ same condition
- APOE p.Ala23= Likely benign ★★ same condition
- APOE p.Asp83= Likely benign ★★ same condition
- APOE p.Arg163His Conflicting classifications of pathogenicity ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/apoe-p-arg176pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown